comparemela.com

Latest Breaking News On - Anti vegf - Page 3 : comparemela.com

Step Therapy for Patients With DME

Experts discuss insurer mandated step therapy and how to navigate treatment options for patients with diabetic macular edema (DME).

United statesJonathan jonischVeeral shethEhsan rahimyBali khanAmerican academy of ophthalmologyAmerican academyMedicare advantageDiabetic macular edemaAge related macular degenerationAnti vegfFirst lineStep therapy

Efficacy of Faricimab in Clinical Trails

Experts discuss clinical trials on the efficacy of faricimab and how they utilize this therapy in their practice.

Jonathan jonischVeeral shethEhsan rahimyBali khanHoly grailAnti vegfAge related macular degenerationMacular degenerationDiabetic macular edema

ASRS 2023: Intended vs Actual Treatment Intervals Between Intravitreal Anti-VEGF Injections: Effects of Treatment Days

In the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended.

United statesBaylor college of medicineChristinay wengBen taubAmerican society of retina specialists in seattleFellowship programCullen eye instituteModern retinaBaylor collegeAmerican societyRetina specialistsBen taub general hospitalAnti vegf

Key Findings of Protocol T Study

Experts discuss the results of Protocol T study comparing anti-vascular endothelial growth factor (Anti-VEGF) agents for the treatment of diabetic macular edema (DME).

Ehsan rahimyBali khanJonathan jonischVeeral shethDiabetic macular edemaNeovascular amdAge related macular degenerationAnti vegf

Key Findings of DRCR Protocol AC Study

Experts discuss the recent DRCR Protocol AC study comparing aflibercept monotherapy vs bevacizumab first therapy for patients with diabetic macular edema (DME).

Veeral shethJonathan jonischEhsan rahimyNew england journalDiabetic macular edemaAge related macular degenerationAnti vegfFirst line

vimarsana © 2020. All Rights Reserved.